K-755 Phase 1 study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224071

Enrollment

Registered

2018-10-01

Start date

2018-09-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy males

Interventions

investigational material(s) Generic name etc : K-755 INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : Oral dose contr

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: healthy males

Exclusion criteria

Exclusion criteria: subjects who having a history of drug allergy

Design outcomes

Primary

Measure	Time frame
safety adverse events, adverse drug reactions incidence rate	—

Secondary

Measure	Time frame
safety clinical tests change from before administration	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026